ADIAL PHARMACEUTICALS, INC. 10-Q filing
Filed 2025-08-13 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-075695
- Form type
- 10-Q
- CIK
- 0001513525
- Primary document
- https://www.sec.gov/Archives/edgar/data/1513525/000121390025075695/ea0251100-10q_adial.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADIAL PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-4.2M | - | - |
| Net Income | $-4.2M | - | - |
| Eps Basic | -0.49 | - | - |
| Eps Diluted | -0.49 | - | - |
| Cash And Equivalents | $5.9M | - | - |
| Total Assets | $6.8M | - | - |
| Total Liabilities | $1.2M | - | - |
| Shareholders Equity | $5.6M | - | - |
| Operating Cash Flow | $-3.3M | - | - |